UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
about
The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast CancerThe integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exerciseLeptin and the adrenal gland.Lower leptin levels in young non-obese male smokers than non-smokers.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults.Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice.Developmental origins of obesity: programmed adipogenesisLeptin and ghrelin in relation to Helicobacter pylori status in adult males.Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample.Serum leptin level is reduced in non-obese subjects with type 2 diabetes.Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: research priorities and needs.Leptin levels in patients with type 1 diabetes receiving intensive insulin therapy compared with those in patients receiving conventional insulin therapy.Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.Two isoforms of the leptin receptor are enhanced in pregnancy-specific tissues and soluble leptin receptor is enhanced in maternal serum with advancing gestation in the baboon.Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes.Investigation of the leptin levels in the blood serum of Cyprinus carpio (Linnaeus, 1758) and Capoeta trutta (Heckel, 1843).Weight loss and leptin changes in individuals with type 2 diabetes.Leptin and plasminogen activator inhibitor-1 levels in children on chronic dialysis.Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes.Serum leptin levels are not influenced by physical training in type 2 diabetes mellitus patients.Basal and stimulated plasma leptin in diabetic subjects.Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy.Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes.Beta 3-adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients.
P2860
Q26750644-22951831-8706-4E80-9D1A-1F680D362537Q26861527-8C2CF38B-CCAA-4E3B-B122-675C0BA229A3Q30662008-E7967CBB-49D8-466B-BA25-5E0CA61E270AQ33781865-2796D7C9-39E4-4027-B60F-24704F03D942Q33846858-FD64C467-F730-48DB-AE7C-0979BC331361Q34577978-0EAFC702-8708-471F-8C2F-8861788E3C6CQ34992896-C6AA38E2-8854-4682-BF4C-35EB2885EF89Q35101262-393B95A2-B1DF-4F0D-9822-6ED696886702Q35685308-15869F3A-4A49-4EE9-8162-77F19A1CF46FQ36584588-1AF87711-A9B9-4B47-93A5-17497D5E0FEBQ36732658-A1C41F13-FB2F-4CFC-B73A-70D80182F872Q36834958-F6040D4A-DCA8-4968-987A-AFE6D4BD3919Q36957442-F815CE5F-2C0D-413E-AD2B-9F8F8DB43728Q37424332-A88EF011-74EE-438F-A80A-B9DB8B0B839CQ37831911-7B0781A9-BB4B-4F2E-9FC8-614D35DDAD71Q39197741-ED52B24D-F780-4F35-9FD0-961D7612422AQ39547921-C012BF7D-18BC-4D6C-BD20-EBA1FE41A98AQ41716392-31744683-74DF-4FC2-BF3C-4F6CDB4359CEQ44144528-73F5563A-BE84-4441-9294-F37E98E0895FQ44215074-D1706B63-5B5B-4CAA-A7E0-00BE37D5A622Q44989536-718FE467-F7B0-4F3C-BD7C-11DE36E4D3F5Q45061195-F822F4B0-675A-47F9-86BD-FFB8B9CDB13EQ46808214-C0C98BB3-5CAE-42C5-9529-B3412D381E36Q47268571-515D1FAD-6064-4A2E-A847-0F8AA9208D7CQ47952253-E7592DB5-23B5-46DF-9993-1C0DC5ABF037Q50518093-21CD82FD-CDDD-4B84-B297-75967F10798CQ51550689-B67E0EDC-AFAA-4052-AE89-6962CBF7D5EEQ51559799-F2BCEEE2-5672-47BF-9ABF-38D13FF83596Q51561377-8EAE9F1B-B1E7-47CF-B21B-C38088638696Q51564436-81A3B0D9-14A8-4DF4-A320-34B653F17DE7Q54100147-05AB403D-71A9-4551-A4B8-7436B152343D
P2860
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
@en
type
label
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
@en
prefLabel
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
@en
P2093
P356
P1476
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects
@en
P2093
P304
P356
10.1210/JCEM.82.2.3744
P407
P577
1997-02-01T00:00:00Z